Nuritas UK Limited
Registered name: NURITAS UK LIMITED
Nuritas UK Limited made £1.2m revenue and £88.8k profit in the year to 31 Dec 2025.
Nuritas UK Limited’s revenue grew 17% to £1.2m in the year to 31 Dec 2025, with £88.8k profit and 4 employees. The company is classified under “research and experimental development on biotechnology” and is based in London; we hold 5 years of its filed accounts.
- Status
- Active
- Location
- London, London
- Age
- 8 yrs · since 2018
- Type
- Private Limited Company
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Dec 2021 | 31 Dec 2022 | 31 Dec 2023 | 31 Dec 2024 | 31 Dec 2025 |
|---|---|---|---|---|---|
| Disclosure | No P&L | Full P&L | Full P&L | Full P&L | Full P&L |
| Profit & loss | |||||
| Revenue (turnover) | — | £327k | £321k | £982k | £1.2m |
| Cost of sales | — | — | — | £0 | £0 |
| Gross profit | — | £327k | £321k | £982k | £1.2m |
| Operating profit | — | £38.2k | £18k | £87.1k | £88.8k |
| Profit before tax | — | £38.2k | £18k | £87.1k | £88.8k |
| Profit after tax | — | £38.2k | £18k | £87.1k | £88.8k |
| Profit (best available) | — | £38.2k | £18k | £87.1k | £88.8k |
| Employees (average) | 1 | 1 | 2 | 4 | 4 |
| Ratios | |||||
| Profit margin | — | 11.7% | 5.6% | 8.9% | 7.7% |
| Gross margin | — | 100% | 100% | 100% | 100% |
| Revenue per employee | — | £327k | £161k | £245k | £288k |
| Profit per employee | — | £38.2k | £9k | £21.8k | £22.2k |
| Growth (year on year) | |||||
| Revenue growth | — | — | ▼1.6% | ▲205.4% | ▲17.2% |
| Profit growth | — | — | ▼52.9% | ▲384% | ▲2% |
| Headcount growth | — | 0% | ▲100% | ▲100% | 0% |
| Balance sheet — indirect signals, not revenue | |||||
| Cash at bank | £47.8k | £37.1k | £17.3k | £532 | £13.4k |
| Net assets | −£362k | −£324k | −£306k | −£219k | −£130k |
| Current assets | £47.8k | £37.1k | £17.3k | £532 | £13.4k |
| Deferred income | — | — | — | £188k | £107k |
| Source | FullAccounts · bulk data Feb 2024 | FullAccounts · bulk data Feb 2024 | FullAccounts · bulk data Sep 2024 | FullAccounts · bulk data Jun 2026 | FullAccounts · bulk data Jun 2026 |
How the business works
- Profit margin
- 7.7%
- Profit ÷ revenue.
- Gross margin
- 100%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £288k
- Revenue ÷ average employees.
- Profit per employee
- £22.2k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- 9.3%
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- —
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now −£130k
- Cash at bank
- ▲2425%
- Now £13.4k
- Headcount
- 0%
- Now 4
- Deferred income
- ▼43%
- Now £107k
- Fixed assets
- —
- Now —
Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.
Similar profitable businesses
- Adorx Therapeutics LimitedEdinburgh · Research and experimental development on biotechnology
- Revenue
- £1.2m
- Profit
- £211k
- Staff
- 0
- Clinicology Ltd.Guildford · Research and experimental development on biotechnology
- Revenue
- £1.4m
- Profit
- £79.1k
- Staff
- 7
- Collaborative Community Against Coronavirus CICLondon · Research and experimental development on biotechnology
- Revenue
- £786k
- Profit
- £29.9k
- Staff
- 0
- Takara Bio UK LtdLondon · Research and experimental development on biotechnology
- Revenue
- £3.1m
- Profit
- £97.2k
- Staff
- 9
Sources
Latest figures from FullAccounts for the year to 31 Dec 2025 (profit £88.8k), from the Companies House accounts bulk data published Jun 2026. Spotted an error? Request a correction.
Updated from Companies House on 21 Oct 2026
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.